(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(135, '<div id="spr0_aef70c5"><div id="spr1_aef70c5" class="kern slide"><img id="img0_aef70c5" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aef70c5" class="kern slide"><div id="spr3_aef70c5" style="top:3.931px;"><div style="width:0px;"><span id="txt0_aef70c5" data-width="192.146484" style="left:150.529px;top:-0.954px;">Example task</span></div></div><div id="spr4_aef70c5" style="left:30.545px;top:78.039px;"><div style="width:0px;"><span id="txt1_aef70c5" data-width="594.958008" style="left:7.2px;top:1.323px;">A 68-year-old woman noted a lump in the left breast about a month ago; she was</span></div><div style="width:0px;"><span id="txt2_aef70c5" data-width="628.760742" style="left:7.2px;top:22.923px;">referred to the breast cancer clinic, where she was diagnosed with breast cancer.  The</span></div><div style="width:0px;"><span id="txt3_aef70c5" data-width="640.995117" style="left:7.2px;top:44.523px;">tumour is 6 cm size with enlarged elastic mobile axillary lymph nodes.  Chest X-ray, liver</span></div><div style="width:0px;"><span id="txt4_aef70c5" data-width="607.306641" style="left:7.2px;top:66.123px;">ultrasound and liver function tests show no signs of distant spread.  Tumour biopsy</span></div><div style="width:0px;"><span id="txt5_aef70c5" data-width="647.885742" style="left:7.2px;top:87.723px;">confirmed invasive ductal carcinoma.  Molecular markers show that tumour is oestrogen</span></div><div style="width:0px;"><span id="txt6_aef70c5" data-width="631.212891" style="left:7.2px;top:109.323px;">receptor positive, progesterone receptor positive, HER2 negative.  No family history of</span></div><div style="width:0px;"><span id="txt7_aef70c5" data-width="630.237305" style="left:7.2px;top:130.923px;">breast cancer.  Concomitant conditions include acute MI 5 years ago &amp; history of deep</span></div><div style="width:0px;"><span id="txt8_aef70c5" data-width="467.630859" style="left:7.2px;top:152.523px;">vein thrombosis; general condition is good for the patient’s age.</span></div><div style="width:0px;"><span id="txt9_aef70c5" data-width="625.086914" style="left:7.2px;top:195.723px;">Present case summary to the class.  Compare the treatments below; suggest which of</span></div><div style="width:0px;"><span id="txt10_aef70c5" data-width="329.273438" style="left:7.2px;top:217.323px;">them may be suitable and which is not, why?</span></div><div style="width:0px;"><span id="txt11_aef70c5" data-width="647.173828" style="left:7.2px;top:260.523px;">1. Immediate mastectomy; after surgery: radiotherapy, adjuvant Tamoxifen for 5 years +</span></div><div style="width:0px;"><span id="txt12_aef70c5" data-width="146.680664" style="left:7.2px;top:282.123px;">Herceptin for 1 year</span></div><div style="width:0px;"><span id="txt13_aef70c5" data-width="628.189453" style="left:7.2px;top:315.723px;">2. Neo-adjuvant Letrozole for 3 months, reassessment after 3 months to decide about</span></div><div style="width:0px;"><span id="txt14_aef70c5" data-width="286.215820" style="left:7.2px;top:337.323px;">the surgery type and further treatment</span></div><div style="width:0px;"><span id="txt15_aef70c5" data-width="639.254883" style="left:7.2px;top:370.923px;">3. Neo-adjuvant Fazlodex for 3 months followed by mastectomy &amp; radiotherapy, then 5</span></div><div style="width:0px;"><span id="txt16_aef70c5" data-width="194.150391" style="left:7.2px;top:392.523px;">years of adjuvant Fazlodex</span></div><div style="width:0px;"><span id="txt17_aef70c5" data-width="482.422852" style="left:7.2px;top:426.123px;">Suggest what might be missed in the assessment and treatments?</span></div></div></div></div>');})();